790
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Immunohistochemical Patterns of Pituitary Adenomas in Southeastern Nigeria, a 10-year Histopathologic Review

, ORCID Icon, , &
Article: 2245587 | Received 21 Apr 2023, Accepted 03 Aug 2023, Published online: 14 Aug 2023

references

  • Bǎlinişteanu B, Ceauşu RA, Cîmpean AM, et al. Conventional examination versus immunohistochemistry in the prediction of hormone profile of pituitary adenomas. An analysis on 142 cases. Rom J Morphol Embryol. 2012;52:1041–9.
  • Ndubuisi C, Ohaegbulam S, Iroegbu L, et al. Histologically confirmed intracranial tumors managed at Enugu, Nigeria. J Neurosci Rural Pract. 2017;8(4):585. doi: 10.4103/jnrp.jnrp_155_17
  • Salami A, Malomo A, Shokunbi T, et al. Pattern of pituitary adenomas in a West African ospital. Pathology. 2014;46(2):119–120. doi: 10.1097/01.PAT.0000454506.80556.c0
  • Salami A, Malomo A, Shokunbi T, et al. Immunohistochemical analysis of pituitary adenomas in a West African Hospital. African J Neurol Sci. 2013;32(2):72–80.
  • Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: A systematic review. Cancer. 2004;101(3):613–619. doi: 10.1002/cncr.20412
  • Idowu O, Akang E, Malomo A. Symptomatic primary intracranial neoplasms in Nigeria, West Africa. J Neurol Sci. 2007;24(3):212–218.
  • Igun G. Diagnosis and management of brain tumours at Jos University teaching hospital, Nigeria. East Afr Med J. 2001;78(3):148–151. doi: 10.4314/eamj.v78i3.9082
  • Salami A, Akang E, Adefolarin M. Recent advances in the pathology of pituitary adenomas. J Morphol Sci. 2015;32(1):043–052. doi: 10.4322/jms.055414
  • Young B, Woodford P, O‘Dowd G. Functional histology. 6th ed. wheater’s functional histology: a Text and colour Atlas. Philadelphia, PA: Churchill Livingston, Elsevier; 2014. p. 318–322.
  • Guyton AC, Hall JE. Pituitary hormones and their control by the hypothalamus textbook of medical physiology. 12th ed. Philadelphia, PA: Saunders, Elsevier; 2011. p. 895–906.
  • Kumar V, Abbas AK, Aster JC. Robbins and cotran pathologic basis of disease. 9th ed. Philadelphia, PA: Elsevier, Saunders; 2015. p. 1073–1139.
  • Syro LV, Rotondo F, Ramirez A, et al. Progress in the diagnosis and classification of pituitary adenomas. Front Endocrinol. 2015;6:97. doi: 10.3389/fendo.2015.00097
  • Syro LV, Builes CE, Di Ieva A, et al. Improving differential diagnosis of pituitary adenomas. Expert Rev Endocrinol Metab. 2014;9(4):377–386. doi: 10.1586/17446651.2014.922412
  • Osamura RY, Lopes MBS, Grossman A, et al. WHO classification of tumours of the pituitary. In: Lloyd RV, Osamura RY, and Klöppel RJ, editors WHO classification of tumours of endocrine glands. 4th ed. Lyon, France: IARC; 2017. p. 11–63.
  • Inoshita N, Nishioka H. The 2017 WHO classification of pituitary adenoma: overview and comments. Brain Tumor Pathol. 2018;35(2):51–56. doi: 10.1007/s10014-018-0314-3
  • Pérez-López C, Zamarrón Á, Isla A, et al. ¿Es práctica la actual clasificación de la OMS para adenomas hipofisarios? Endocrinol Diabetes Nutr. 2022;69(3):234–235. doi: 10.1016/j.endien.2020.10.014
  • Nosé V. The 11th meeting of the international pituitary pathology society october 16–20, 2009 Awaji Island, Japan. Endocr Pathol. 2010;21(1):48–68. doi: 10.1007/s12022-010-9109-8
  • Lopes MBS. The 2017 world health organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 2017;134:521–535. doi: 10.1007/s00401-017-1769-8
  • Mete O, Lopes MB. Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol. 2017;28(3):228–243. doi: 10.1007/s12022-017-9498-z
  • Laws ER, Penn DL, Repetti CS. Advances and controversies in the classification and grading of pituitary tumors. J Endocrinol Invest. 2019;42:129–135. doi: 10.1007/s40618-018-0901-5
  • Al-Shraim M, Asa SL. The 2004 world health organization classification of pituitary tumors: what is new? Acta Neuropathol. 2006;111(1):1–7.
  • Saeger W. The 2017 WHO classification of pituitary tumors. Pathologe. 2021;42(3):333–351. doi: 10.1007/s00292-021-00932-x
  • Asa SL, Mete O, Perry A, et al. Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol. 2022 Mar;33(1):6–26. doi: 10.1007/s12022-022-09703-7
  • Wan XY, Chen J, Wang JW, et al. Overview of the 2022 WHO classification of pituitary adenomas/pituitary neuroendocrine tumors: Clinical practices, controversies, and perspectives. Curr Med Sci. 2022 Dec;42(6):1111–1118. doi: 10.1007/s11596-022-2673-6
  • Lim CT, Korbonits M Update on the clinicopathology of pituitary adenomas. Endocr Pract. 2018; EP – 2018 – 0034. Available from: http://journals.aace.com/doi/10.4158/EP - 2018- 0034.
  • Jibrin P, Ibebuike K, Ado-Wanka AN. Histo-pathological pattern of intracranial tumours in the national Hospital, Abuja. Afr Health Sci. 2018;18(2):281–286. doi: 10.4314/ahs.v18i2.12
  • Gandaho HJ, Adeleye AO, Kerekou A, et al. Constraints in the neurosurgical management of pituitary tumours in an African Developing Country: A 5-Year observational study from Benin Republic. Afr J Med Sci. 2016;45(3):261–267.
  • M KJ. ANALYSIS of PITUITARY TUMOURS: RETROSPECTIVE STUDY at CHRIS HANI BARAGWANATH and CHARLOTTE MAXEKE JOHANNESBURG ACADEMIC HOSPITALS, KENNEDY JOHN MATSHANA a research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, Jo [Internet]. Johannesburg, South Africa; 2010. 1–44 p. Available from: http://hdl.handle.net/10539/8798
  • Mello PA, Naves LA, Pereira Neto A, et al. Clinical and laboratorial characterization and post-surgical follow-up of 87 patients with non-functioning pituitary macroadenomas. Arq Neuropsiquiatr. 2013;71(5):307–312. doi: 10.1590/0004-282x20130026
  • Raappana A, Koivukangas J, Ebeling T, et al. Incidence of pituitary adenomas in Northern Finland in 1992-2007. J Clin Endocrinol Metab. 2010;95(9):4268–4275. doi: 10.1210/jc.2010-0537
  • Shamim MS, Bari ME, Khursheed F, et al. Pituitary adenomas: Presentations and outcomes in a South Asian country. Can J Neurol Sci. 2008;35(2):198–203. doi: 10.1017/S0317167100008635
  • GG T, KD R, F Y, et al. Magnitude, Clinical presentation and outcome of patients with pituitary lesions: An experience from tikur anbessa specialized Hospital, Ethiopia. Endocrinol Metab Syndr. 2017;6(02):263. Internet Available from. www.omicsonline.org/open-access/magnitude-clinical-presentation-and-outcome-of-patients-with-pituitary-lesionsan-experience-from-tikur-anbessa-specialized-hospita-2161-1017-1000263.php?aid=87782
  • Matshana K Analysis of pituitary tumours: Retrospective Study at Chris Hani Baragwanath and Charlotte Maxeke Johannesburg Academic Hospitals: a research report submitted to the faculty of health sciences, University Of The Witwatersrand, Johannesburg, South Africa; 2010. p. 1–44.
  • Daly AF, Rixhon M, Adam C, et al. High prevalence of pituitary adenomas: a cross-sectional study in the Province of Liege. Belgium J Clin Endocrinol Metab. 2007;91(12):4769–4775. doi: 10.1210/jc.2006-1668
  • Daly AF, Beckers A. The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am. 2020 Sep;49(3):347–355. doi: 10.1016/j.ecl.2020.04.002
  • Akkus G, Karagun B, Çetinalp NE, et al. Clinical relevance and immunohistochemical patterns of silent pituitary adenomas: 10 years of single-centre experience. Curr Med Imaging. 2021;17(2):310–317. doi: 10.2174/1573405616666201223125642